BlackRock Investment Management’s TG Therapeutics TGTX Stock Holding History

BlackRock Investment Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$683K	Sell	146,838 -2,025	-1%	-$11.9K	﹤0.01%	2908
2016 Q3	$1.15M	Sell	148,863 -224	-0.2%	-$1.44K	﹤0.01%	2569
2016 Q2	$903K	Buy	149,087 +8,102	+6%	+$65.9K	﹤0.01%	2705
2016 Q1	$1.2M	Buy	140,985 +17,090	+14%	+$150K	﹤0.01%	2366
2015 Q4	$1.48M	Buy	123,895 +9	+0%	+$114	﹤0.01%	2297
2015 Q3	$1.25M	Sell	123,886 -1,557	-1%	-$23.2K	﹤0.01%	2432
2015 Q2	$2.08M	Buy	125,443 +41,382	+49%	+$655K	﹤0.01%	2197
2015 Q1	$1.3M	Buy	84,061 +6,027	+8%	+$91.3K	﹤0.01%	2351
2014 Q4	$1.24M	Buy	78,034 +9,424	+14%	+$123K	﹤0.01%	2396
2014 Q3	$732K	Buy	68,610 +870	+1%	+$8.07K	﹤0.01%	2729
2014 Q2	$636K	Buy	67,740 +18,635	+38%	+$119K	﹤0.01%	2906
2014 Q1	$339K	Buy	49,105 +6,775	+16%	+$40.1K	﹤0.01%	3117
2013 Q4	$165K	Hold	42,330	–	–	﹤0.01%	3237
2013 Q3	$213K	Buy	42,330 +12,182	+40%	+$74.5K	﹤0.01%	3176
2013 Q2	$193K	Buy	+30,148	New	+$193K	﹤0.01%	3167

Other funds holding TGTX

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock Investment Management's TGTX Position: Q4 2016 in Review

BlackRock Investment Management reduced its TG Therapeutics (TGTX) stake by 1.4% in Q4 2016, selling an estimated $11.9K and leaving 146,838 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #2908.

BlackRock Investment Management first reported a position in TGTX in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.08M in Q2 2015. 91 funds tracked by Wall St. Rank hold TGTX as of Q4 2016.

BlackRock Investment Management held 146,838 shares of TG Therapeutics worth $683K as of Q4 2016.
BlackRock Investment Management sold 2,025 TG Therapeutics shares in Q4 2016, an estimated $11.9K.
TG Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2908 holding.
BlackRock Investment Management first reported a position in TG Therapeutics in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's TG Therapeutics position peaked at $2.08M in Q2 2015.
91 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.